Welcome to LookChem.com Sign In|Join Free
  • or
Propanoic acid, 2-(4-fluorophenoxy)-2-methyl-, ethyl ester is a complex organic compound with the chemical formula C12H15FO3. It is an ester derivative of propanoic acid, featuring a 4-fluorophenoxy group attached to the 2-methylpropanoic acid backbone. Propanoic acid, 2-(4-fluorophenoxy)-2-methyl-, ethyl ester is characterized by its molecular structure, which includes a fluorine atom in the para position of the phenoxy group, a methyl group on the 2-carbon of the propanoic acid, and an ethyl ester group. It is a colorless to pale yellow liquid with a specific chemical structure that gives it unique properties and potential applications in various fields, such as pharmaceuticals or chemical research. The compound's specific name reflects its structure, indicating the presence of a propanoic acid core, a 4-fluorophenoxy substituent, a methyl group, and an ethyl ester functional group.

587-12-2

Post Buying Request

587-12-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

587-12-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 587-12-2 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,8 and 7 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 587-12:
(5*5)+(4*8)+(3*7)+(2*1)+(1*2)=82
82 % 10 = 2
So 587-12-2 is a valid CAS Registry Number.

587-12-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 2-(4-fluorophenoxy)-2-methylpropanoate

1.2 Other means of identification

Product number -
Other names Ethyl-2-(4-fluorphenoxy)-2-methylpropionat

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:587-12-2 SDS

587-12-2Relevant academic research and scientific papers

Design, synthesis of novel, potent, selective, orally bioavailable adenosine A2A receptor antagonists and their biological evaluation

Basu, Sujay,Barawkar, Dinesh A.,Thorat, Sachin,Shejul, Yogesh D.,Patel, Meena,Naykodi, Minakshi,Jain, Vaibhav,Salve, Yogesh,Prasad, Vandna,Chaudhary, Sumit,Ghosh, Indraneel,Bhat, Ganesh,Quraishi, Azfar,Patil, Harish,Ansari, Shariq,Menon, Suraj,Unadkat, Vishal,Thakare, Rhishikesh,Seervi, Madhav S.,Meru, Ashwinkumar V.,De, Siddhartha,Bhamidipati, Ravi K.,Rouduri, Sreekanth R.,Palle, Venkata P.,Chug, Anita,Mookhtiar, Kasim A.

supporting information, p. 681 - 694 (2017/02/05)

Our initial structure-activity relationship studies on 7-methoxy-4-morpholino-benzothiazole derivatives featured by aryloxy-2-methylpropanamide moieties at the 2-position led to identification of compound 25 as a potent and selective A2A adenosine receptor (A2AAdoR) antagonist with reasonable ADME and pharmacokinetic properties. However, poor intrinsic solubility and low to moderate oral bioavailability made this series unsuitable for further development. Further optimization using structure-based drug design approach resulted in discovery of potent and selective adenosine A2A receptor antagonists bearing substituted 1-methylcyclohexyl-carboxamide groups at position 2 of the benzothiazole scaffold and endowed with better solubility and oral bioavailability. Compounds 41 and 49 demonstrated a number of positive attributes with respect to in vitro ADME properties. Both compounds displayed good pharmacokinetic properties with 63% and 61% oral bioavailability, respectively, in rat. Further, compound 49 displayed oral efficacy in 6-OHDA lesioned rat model of Parkinson diseases.

TRIAZOLE DERIVATIVE OR SALT THEREOF

-

Page/Page column 23, (2011/04/18)

[Problem] A compound, which can be used for preventing or treating diseases, in which 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) is concerned, in particular, diabetes, insulin resistance, dementia, schizophrenia and depression, is provided. [Means

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 587-12-2